Approvals/HSA/Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial

Approved

THERAPEUTIC

Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial

ACS Dobfar S.p.A. 2 (ITALY)Demo S.A. (GREECE)SAVIOR LIFETEC CORPORATION (sterile bulk) (TAIWAN)SAVIOR LIFETEC CORPORATION Tainan Site (block A) (sterile bulk) (TAIWAN)SAVIOR LIFETEC CORPORATION Tainan Site (block B) (sterile bulk) (TAIWAN)ANFARM HELLAS S.A. (GREECE)🇸🇬 Health Sciences Authority

Approval Date: Sep 19, 2011
Approval ID: 9b45371097eb4782
Company: ACS Dobfar S.p.A. 2 (ITALY)Demo S.A. (GREECE)SAVIOR LIFETEC CORPORATION (sterile bulk) (TAIWAN)SAVIOR LIFETEC CORPORATION Tainan Site (block A) (sterile bulk) (TAIWAN)SAVIOR LIFETEC CORPORATION Tainan Site (block B) (sterile bulk) (TAIWAN)ANFARM HELLAS S.A. (GREECE)
Type: Therapeutic

Approval Details

Approval Id: 9b45371097eb4782
Drug Name: Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial
Product Name: Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial
Approval Number: SIN14014P
Approval Date: 2011-09-19
Registrant: NOVEM HEALTHCARE PTE LTD
Licence Holder: NOVEM PHARMA PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: J01DH02
Atc Item Name: meropenem
Pharma Manufacturer Name: NOVEM PHARMA PRIVATE LIMITED

Active Ingredients

Meropenem trihydrate 1140 mg eqv. to anhydrous meropenem

1000 mg

MEROPENEM TRIHYDRATE 1,140 MG EQV. TO ANHYDROUS MEROPENEM

1,000 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Sep 19, 2011

Approval ID

9b45371097eb4782

Type

Therapeutic

Back to HSA Approvals